Outcomes of single- and two-stage revision total knee arthroplasty for chronic periprosthetic joint infection

医学 假体周围 生存曲线 外科 队列 关节置换术 比例危险模型 内科学 回顾性队列研究 阶段(地层学) 癌症 生物 古生物学
作者
Hosam E. Matar,Benjamin V. Bloch,S. Snape,Peter James
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (8): 1373-1379 被引量:41
标识
DOI:10.1302/0301-620x.103b8.bjj-2021-0224.r1
摘要

Aims Single-stage revision total knee arthroplasty (rTKA) is gaining popularity in treating chronic periprosthetic joint infections (PJIs). We have introduced this approach to our clinical practice and sought to evaluate rates of reinfection and re-revision, along with predictors of failure of both single- and two-stage rTKA for chronic PJI. Methods A retrospective comparative cohort study of all rTKAs for chronic PJI between 1 April 2003 and 31 December 2018 was undertaken using prospective databases. Patients with acute infections were excluded; rTKAs were classified as single-stage, stage 1, or stage 2 of two-stage revision. The primary outcome measure was failure to eradicate or recurrent infection. Variables evaluated for failure by regression analysis included age, BMI, American Society of Anesthesiologists grade, infecting organisms, and the presence of a sinus. Patient survivorship was also compared between the groups. Results A total of 292 consecutive first-time rTKAs for chronic PJI were included: 82 single-stage (28.1%); and 210 two-stage (71.9%) revisions. The mean age was 71 years (27 to 90), with 165 females (57.4%), and a mean BMI of 30.9 kg/m 2 (20 to 53). Significantly more patients with a known infecting organism were in the single-stage group (93.9% vs 80.47%; p = 0.004). The infecting organism was identified preoperatively in 246 cases (84.2%). At a mean follow-up of 6.3 years (2.0 to 17.6), the failure rate was 6.1% in the single-stage, and 12% in the two-stage groups. All failures occurred within four years of treatment. The presence of a sinus was an independent risk factor for failure (odds ratio (OR) 4.97; 95% confidence interval (CI) 1.593 to 15.505; p = 0.006), as well as age > 80 years (OR 5.962; 95% CI 1.156 to 30.73; p = 0.033). The ten-year patient survivorship rate was 72% in the single-stage group compared with 70.5% in the two-stage group. This difference was not significant (p = 0.517). Conclusion Single-stage rTKA is an effective strategy with a high success rate comparable to two-stage approach in appropriately selected patients. Cite this article: Bone Joint J 2021;103-B(8):1373–1379.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
沉淀发布了新的文献求助50
2秒前
科目三应助鲤鱼幻香采纳,获得10
2秒前
无奈迎波完成签到,获得积分10
2秒前
le发布了新的文献求助10
3秒前
猫和老鼠发布了新的文献求助10
4秒前
4秒前
羊羊羊发布了新的文献求助10
4秒前
Ricewind发布了新的文献求助10
5秒前
fSSXMSSN完成签到,获得积分10
6秒前
神勇代荷应助蓝天采纳,获得10
7秒前
ding应助任性的山芙采纳,获得10
7秒前
7秒前
搞怪的紫雪完成签到,获得积分10
7秒前
夜捕白日梦完成签到,获得积分10
7秒前
睡个懒觉8完成签到 ,获得积分10
9秒前
脑洞疼应助沉淀采纳,获得50
10秒前
李健应助1111采纳,获得10
10秒前
11秒前
小马甲应助李新宇采纳,获得10
14秒前
边城小子完成签到,获得积分10
14秒前
14秒前
iNk应助泥嚎采纳,获得20
15秒前
雪山飞龙发布了新的文献求助30
15秒前
岸上牛完成签到,获得积分10
15秒前
air233完成签到,获得积分10
17秒前
贪玩的秋柔应助鱼oo采纳,获得10
17秒前
18秒前
18秒前
Jasper应助云仔采纳,获得10
18秒前
欣喜小之完成签到,获得积分10
19秒前
NexusExplorer应助小猪采纳,获得10
20秒前
21秒前
淡淡的小翠完成签到,获得积分10
21秒前
小马甲应助羊羊羊采纳,获得10
21秒前
21秒前
cL发布了新的文献求助10
22秒前
22秒前
传奇3应助修脚大师采纳,获得10
22秒前
自觉柠檬完成签到 ,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 1600
Decentring Leadership 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Intentional optical interference with precision weapons (in Russian) Преднамеренные оптические помехи высокоточному оружию 1000
Atlas of Anatomy 5th original digital 2025的PDF高清电子版(非压缩版,大小约400-600兆,能更大就更好了) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6184364
求助须知:如何正确求助?哪些是违规求助? 8011653
关于积分的说明 16663915
捐赠科研通 5283697
什么是DOI,文献DOI怎么找? 2816564
邀请新用户注册赠送积分活动 1796376
关于科研通互助平台的介绍 1660883